Biotech Startup Maze Therapeutics Strikes $750 Million Deal With Sanofi
Wall Street Journal
Maze Therapeutics has raised about $400 million in venture capital since its 2019 launch on the promise of a platform for using genetic insights to develop new drugs. Now, the biotechnology startup is making good on that potential.